Search results for "homocysteine"

showing 10 items of 116 documents

Low intestinal cholesterol absorption is associated with a reduced efficacy of phytosterol esters as hypolipemic agents in patients with metabolic sy…

2010

Summary Background & aims Phytosterols (PS) lower LDLc, but their effect on metabolic syndrome (MetS) remains unknown. We evaluated whether low-fat milk enriched with PS improves cardiovascular risk factors in these patients. Methods A randomised parallel trial employing 24 moderate-hypercholesterolaemic MetS patients and consisting of two 3-month intervention phases. After a 3-month healthy diet, patients were divided into two intervention groups: diet (n = 10) and diet + PS (n = 14) (2 g/day). A control group of 24 moderate-hypercholesterolaemic patients without MetS (matched in age and BMI) underwent the same procedure. Results Neither dietary intervention nor enrichment of PS induced an…

AdultMalemedicine.medical_specialtyApolipoprotein BHomocysteineLipoproteinsHypercholesterolemiaPopulationCritical Care and Intensive Care MedicineSeverity of Illness IndexCholesterol Dietarychemistry.chemical_compoundRisk FactorsInternal medicinemedicineHumanseducationHypolipidemic AgentsMetabolic Syndromeeducation.field_of_studyNutrition and Dieteticsmedicine.diagnostic_testbiologybusiness.industryAnticholesteremic AgentsPhytosterolsMiddle Agedmedicine.diseaseSitosterolsCholesterolEndocrinologyIntestinal AbsorptionchemistryCardiovascular DiseasesSpainDietary SupplementsIntestinal cholesterol absorptionbiology.proteinFemaleMetabolic syndromebusinessLipid profileBody mass indexLipoproteinClinical Nutrition
researchProduct

Association of C677T polymorphism in MTHFR gene, high homocysteine and low HDL cholesterol plasma values in heterozygous familial hypercholesterolemi…

2010

Aim: to investigate the association of C677T polymorphism in the methylene tetrahydrofolate reductase (MTHFR) gene, homocysteine plasma values (Hcy), and plasma HDL cholesterol in heterozy-gous familial hypercholesterolemia (hFH).Methods: One hundred and twenty-five hFH subjects were studied. Plasma lipid, lipoprotein, vitamin B12, folic acid and Hcy values were determined. C677T polymorphism in the MTHFR gene was detected by SSCP-PCR. Genetic diagnosis of FH was determined by a three-step protocol using SSCP-PCR, Southern blot, long PCR and automatic sequencing.Results: We found significant differences in plasma HDL-C (CC 1.39±0.34, CT 1.33±0.39 and TT 1.14±0.26 mmol/L, p=0.028) between th…

AdultMalemedicine.medical_specialtyHeterozygoteApolipoprotein BHomocysteineHypercholesterolemiaFamilial hypercholesterolemiaPolymerase Chain Reactionchemistry.chemical_compoundInternal medicineGenotypeInternal MedicinemedicineHumansVitamin B12HomocysteineMethylenetetrahydrofolate Reductase (NADPH2)Polymorphism Single-Stranded ConformationalApolipoproteins BGeneticsPolymorphism GeneticbiologyCholesterolbusiness.industryBiochemistry (medical)Cholesterol HDLMiddle Agedmedicine.diseaseEndocrinologychemistryReceptors LDLMethylenetetrahydrofolate reductaseMutationbiology.proteinFemaleCardiology and Cardiovascular MedicinebusinessLipoproteinJournal of atherosclerosis and thrombosis
researchProduct

Plasma resistin levels are associated with homocysteine, endothelial activation, and nitrosative stress in obese youths.

2013

To evaluate whether serum resistin levels are related to cardiovascular risk in obese children.Cross-sectional study of 110 children (40 normal weight and 70 severely obese). Clinical and biochemical parameters, including lipid profile, fasting glucose and insulin, and homocysteine, were determined. The levels of adipokines (adiponectin, leptin, and resistin), markers of inflammation (high-sensitivity C-reactive protein (hs-CRP)), endothelial activation (serum concentrations of soluble intercellular and vascular cellular adhesion molecule-1 (sICAM-1, sVCAM-1)), and oxidative/nitrosative stress (malondialdehyde and urinary nitrate/nitrite) were measured.A partial correlation adjusted by gend…

AdultMalemedicine.medical_specialtyHomocysteineAdolescentNitrosationClinical BiochemistryAdipokineBody Mass IndexEndothelial activationchemistry.chemical_compoundYoung AdultInternal medicinemedicineHumansResistinObesityEndothelial dysfunctionHomocysteinemedicine.diagnostic_testAdiponectinbusiness.industryLeptinGeneral Medicinemedicine.diseaseEndocrinologychemistryResistinFemaleEndothelium VascularbusinessLipid profilehormones hormone substitutes and hormone antagonistsClinical biochemistry
researchProduct

C-reactive protein but not soluble CD40 ligand and homocysteine is associated to common atherosclerotic risk factors in a cohort of coronary artery d…

2009

Abstract Objectives One third to one half of the variation in vascular disease occurrence remains unexplained by traditional risk factors. Since atherosclerosis may, in part, be an inflammatory disease, circulating factors related to inflammation may be predictors of cardiovascular disease. The aim of this study was to evaluate the association between common atherosclerotic risk factors and markers of inflammation. Design and methods Serum levels of soluble CD40 (sCD40L), high-sensitive C-reactive protein (hs-CRP) and homocysteine (Hcy) were measured in 251 patients selected from a series of 438 subjects affected by previous myocardial infarction, angina or other cardiovascular diseases. Re…

AdultMalemedicine.medical_specialtyHomocysteineClinical BiochemistryCD40 LigandEnzyme-Linked Immunosorbent AssayDiseaseCoronary Artery DiseaseCoronary artery diseaseAnginaCohort Studieschemistry.chemical_compoundRisk FactorsInternal medicinemedicineCD40Humansc-reactiveMyocardial infarctionHomocysteineFramingham Risk Scorebiologybusiness.industryVascular diseaseC-reactive proteinGeneral MedicineMiddle Agedmedicine.diseaseC-Reactive Proteinchemistrybiology.proteinCardiologyFemalebusiness
researchProduct

Age, homocysteine, and oxidative stress: Relation to hypertension and type 2 diabetes mellitus

2010

Abstract OBJECTIVES: Hyperhomocysteinemia and oxidative stress are independent risk factors for cardiovascular events, which occur more frequently in old age. We evaluated these parameters in relation to age and the presence of hypertension and type 2 diabetes mellitus. METHODS: Two hundred eighty-two subjects (female/male: 142/140; 141 were >65 years and 141 were <65 years; mean age 73.9 +/- 6.6 years and 52.5 +/- 8.2 years, respectively) were randomly recruited from those attending our institution. Blood pressure, anthropometric parameters, oxidative stress parameters (reactive oxygen species [ROS] and malondialdehyde [MDA]), and homocysteine levels were evaluated in participants. RESULTS…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaAgingSettore MED/09 - Medicina InternaHomocysteineMedicine (miscellaneous)Type 2 diabetesmedicine.disease_causechemistry.chemical_compoundInternal medicineDiabetes mellitusMalondialdehydeMedicineHumansHomocysteineAgedNutrition and Dieteticsbusiness.industryAge FactorsType 2 Diabetes MellitusMiddle Agedmedicine.diseaseMalondialdehydeaging homocysteine oxidative stress hypertension type 2 diabetesOxidative StressBlood pressureEndocrinologychemistryDiabetes Mellitus Type 2HypertensionFemalebusinessReactive Oxygen SpeciesOxidative stress
researchProduct

Homocysteine levels and the metabolic syndrome in a Mediterranean population: A case-control study

2011

Hyperhomocysteinemia (HH) and metabolic syndrome (MS) are associated with increased cardiovascular risk. However, whether there is a link between MS or its components and homocysteine levels in a population without cardiovascular disease is not well established. We conducted a case-control study in 61 MS patients (41 males, 20 females, aged 51 ± 11 years) and in 98 controls without MS (59 males, 39 females, aged 50 ± 10 years) to ascertain the association between MS and HH, and with inflammatory markers. MS was classified according to the updated ATPIII criteria [17]. No differences in homocysteine levels were observed when comparing MS patients and controls (12.0 ± 3.18 μM vs. 11.9 ± 3.5 μ…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaHomocysteinePhysiologyPopulationHyperhomocysteinemiachemistry.chemical_compoundPhysiology (medical)Internal medicineDiabetes mellitusHumansMedicineeducationHomocysteineAbdominal obesityMetabolic Syndromeeducation.field_of_studyCreatininebusiness.industryHypertriglyceridemiaHematologyMiddle Agedmedicine.diseaseEndocrinologychemistryCardiovascular DiseasesCase-Control StudiesFemalemedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinessClinical Hemorheology and Microcirculation
researchProduct

Drug-induced pertubation of the aminothiol redox-status in patients with epilepsy: improvement by B-vitamins.

2008

Summary Objectives Patients with epilepsy have excess morbidity and mortality due to ischemic cardiovascular disease. Many of these patients have elevated concentrations of plasma total homocysteine (Hcy), which is an acknowledged risk factor for cardiovascular disease, venous thromboembolic disease, foetal malformations and dementia. Hyperhomocysteinemia may have negative effects through mechanisms involving oxidative damage. In the present study, we have investigated the aminothiol redox-status in patients on antiepileptic drugs. Thereafter, in a subset of patients with elevated total Hcy, we evaluated the effect of B-vitamin therapy. Methods In the first part of the study, 101 patients o…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaHomocysteinemedicine.medical_treatmentRiboflavinHyperhomocysteinemiaRiboflavinchemistry.chemical_compoundFolic AcidMethionineVitamin B DeficiencyInternal medicinemedicineHumansCysteineMethionineEpilepsybusiness.industryValproic AcidCase-control studyPyridoxineDipeptidesmedicine.diseasePyridoxineSurgeryB vitaminsEndocrinologyAnticonvulsantCarbamazepineNeurologychemistryLiverCase-Control StudiesPhenobarbitalPhenytoinDrug EvaluationAnticonvulsantsFemaleNeurology (clinical)businessOxidation-ReductionPrimidonemedicine.drugEpilepsy research
researchProduct

Methionine synthase reductase (MTRR) A66G polymorphism is not related to plasma homocysteine concentration and the risk for vascular disease.

2009

Epidemiological evidence has revealed that hyperhomocysteinemia increases the risk for vascular disease. Methionine Synthase Reductase (MTRR) is one of several key enzymes in the homocysteine metabolic pathway and its mutant forms have been implicated in abnormal homocysteine accumulation. In this study, we determined total plasma homocysteine levels and MTRR A66G polymorphism in 114 patients with vascular disease: 58 patients with deep-vein thrombosis, 56 patients with arterial thrombosis, and 95 healthy subjects from the Sicilian population. Our data confirmed that, as already reported, moderately elevated t-Hcy levels are correlated with an increased risk of vascular disease. In our stud…

AdultMalemedicine.medical_specialtyHyperhomocysteinemiaMethyltransferaseHomocysteineClinical BiochemistryPopulationMethionine synthase reductase homocysteinePolymorphism Single NucleotidePathology and Forensic Medicinechemistry.chemical_compoundInternal medicineMedicineHumansGenetic Predisposition to DiseaseVascular DiseaseseducationMolecular BiologyHomocysteineAgededucation.field_of_studybiologybusiness.industryVascular disease(Methionine synthase) reductaseMiddle Agedmedicine.diseaseMTRRFerredoxin-NADP ReductaseVenous thrombosisEndocrinologyBiochemistrychemistryCase-Control Studiesbiology.proteinFemalebusinessExperimental and molecular pathology
researchProduct

Blood lipids, homocysteine, stress factors, and vitamins in clinically stable multiple sclerosis patients

2009

Abstract Multiple Sclerosis (MS) patients present a decrease of antioxidants and neuroprotective and immunoregulatory vitamins and an increase of total homocysteine (tHcy), cholesterol (CHL), HDL-cholesterol, and of cellular stress markers, variably associated with the different phases of the disease. We compared the blood levels of uric acid, folic acid, vitamins B12, A, and E, tHcy, CHL, HDL-cholesterol, and triglycerides in forty MS patients during a phase of clinical inactivity with those of eighty healthy controls, matched for age and sex. We found higher levels of tHcy (p = 0.032) and of HDL-cholesterol (p = 0.001) and lower levels of vitamin E (p = 0.001) and the ratio vitamin E/CHL …

AdultMalemedicine.medical_specialtyMultiple SclerosisAdolescentHomocysteineEndocrinology Diabetes and Metabolismmedicine.medical_treatmentClinical BiochemistryBlood lipidsClinical nutritionBiologyAntioxidantschemistry.chemical_compoundFolic AcidEndocrinologyHigh-density lipoproteinSettore BIO/10 - BiochimicaInternal medicinemedicineHumansShort PaperVitamin B12Homocysteinelcsh:RC620-627TriglyceridesBiochemistry medicalCholesterolVitamin EBiochemistry (medical)VitaminsMiddle AgedLipidsUric Acidlcsh:Nutritional diseases. Deficiency diseasesEndocrinologychemistryCase-Control StudiesUric acidSettore MED/26 - NeurologiaFemalelipids (amino acids peptides and proteins)Lipids in Health and Disease
researchProduct

Superficial thrombophlebitis in varicose vein disease: the particular role of methylenetetrahydrofolate reductase.

2010

Background The purpose of this study was to compare the genetic background of superficial (SVT) and deep vein thrombosis (DVT). Methods Factor V (FV)-Leiden (G16891A)-, factor II(G20210A)-mutations, protein C- and S, as well as methylenetetrahydrofolate reductase (MTHFR) polymorphisms at C677T and A1298C, and serum homocysteine levels (hcy) were determined in 29 patients with SVT and 26 with DVT. Findings FV- and –II-mutations were less frequent in patients with SVT (2/3) compared with DVT (9/5), respectively ( P &lt; 0.002 in case of FV). However, the frequency of the MTHFR C677T polymorphism was significantly higher in patients with SVT compared with DVT (CT 12 versus 10, and TT 7 versus …

AdultMalemedicine.medical_specialtyPathologyDeep veinMutation MissenseDiseaseGastroenterologyVaricose VeinsInternal medicineVaricose veinsGenotypemedicineHumansSuperficial thrombophlebitisGenetic Predisposition to DiseaseHomocysteineAgedAged 80 and overMethylenetetrahydrofolate Dehydrogenase (NADP)Venous Thrombosisbiologybusiness.industryFactor VGeneral MedicineMiddle AgedThrombophlebitismedicine.diseaseThrombosisVenous thrombosismedicine.anatomical_structureAmino Acid SubstitutionMethylenetetrahydrofolate reductasebiology.proteinFemaleProthrombinmedicine.symptomCardiology and Cardiovascular MedicinebusinessPhlebology
researchProduct